23 May 2013
Keywords: xeloda, filed, eu, stomach, cancer, switzerland-based, drug
Article | 31 July 2006
Switzerland-based drug major Roche says that the European Medicines Agency (EMEA) has accepted the firm's anticancer agent Xeloda
(capecitabine) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 July 2006
7 August 2006
24 July 2006
© 2013 thepharmaletter.com